Article List

WPRIM Management System> DCMS> Chinese Journal of Medical Science Research Management> 2019> 32> 5

Volume: 32 Issue: 5

1. Investigation and analysis on the status quo of education and management on research integrity :Taking hospitals, medical colleges and medical research institutes for example	Page:321—324
2. Analysis of human genetic resources management	Page:325—328
3. Discussion on the construction of research integrity in medical science under new circumstances	Page:329—332
4. Practice of improving the efficiency of scientific and technological innovation in hospital from the perspective of modern hospital management	Page:333—336
5. Problem exploration and measures on the investigator initiated trial from the perspective of scientific research supervision	Page:337—341
6. Study on the status quo and quality evaluation of data graphs and tables based on academic medical journals in Shanghai universities	Page:342—346
7. Practice and exploration of University of Science and Technology of China in improving efficiency during formality examination of the National Natural Science Fund Project	Page:347—352
8. Patent information analysis of 77 medical and health institutions in Zhejiang Province	Page:353—357
9. Discussion on policy of domestic and overseas high-level talents training and introduction	Page:358—363
10. Development strategy of medicine discipline in comprehensive university under the background of "Double First-Class" construction	Page:364—370
11. Analysis of regional research competitiveness of medical subjects in China	Page:371—375
12. Establishment and application of intelligent evaluation system for scientific research performance	Page:376—380
13. Exploration of scientific research management based on bibliometric analysis of SCI research papers published by Beijing Anzhen Hospital, Capital Medical University from 2008 to 2017	Page:381—385
14. Feasibility analysis based on BI evaluation index of SCI journals :Taking the Third Xiangya Hospital as an example	Page:386—391
15. Quality evaluation of Investigator-Initiated Trials at the early approval stage	Page:392—396
16. Analysis of the application mechanism of clinical biobank	Page:397—400